Overall survival of patients with metastatic breast cancer in Sweden: a nationwide studyAntonis Valachis, Henrik Lindman, Jonatan Freilich et al.|British Journal of Cancer|2022Cited by 52
Impact of body mass index on the efficacy of endocrine therapy in patients with metastatic breast cancer - A retrospective two-center cohort studyLuwam Zewenghiel, Antonis Valachis, Henrik Lindman|The Breast|2018Cited by 23
Abstract OT3-30-01: A randomized double-blind placebo controlled phase 3 trial on the effect of Salovum™ and SPC-Flakes™ on abemaciclib-induced gastrointestinal toxicity in early breast cancer – the ASF-BC studyHenrik Lindman, Antonis Valachis, Peter Nygren|Cancer Research|2023Cited by 1
246P Palbociclib dose patterns in Swedish patients with metastatic breast cancer: Evidence from the SIRI studyAntonis Valachis, Maria Jakobsson, Mathias Lilja et al.|Annals of Oncology|2021Cited by 0
Abstract PO4-15-05: Genomic characterization and molecular predictive biomarkers for chemotherapy in a real-world population with metastatic triple-negative breast cancerErik Olsson, Antonis Valachis, Henrik Lindman et al.|Cancer Research|2024Cited by 0